Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sumitomo Chemical Co ( (JP:4005) ) has issued an update.
Sumitomo Chemical reported that its consolidated subsidiary Sumitomo Pharma Co., Ltd. posted sharp year-on-year gains in non-consolidated results for the fiscal year ended March 31, 2026, driven by an 82.9% rise in net sales to ¥249.5 billion and a more than fourfold increase in ordinary income. Despite these sizable movements at the subsidiary level, the parent said the overall impact on its consolidated earnings forecast remains immaterial.
The surge in Sumitomo Pharma’s performance reflects the August 2025 acquisition of substantially all U.S. assets, including patent rights, for three key products from group entities Sumitomo Pharma Switzerland GmbH and Urovant Sciences GmbH, allowing the company to book their sales directly. Ordinary income was further buoyed by dividend income from the Swiss subsidiary, while net income benefited from gains on sales of shares in affiliates following the partial transfer of an Asian business stake, underscoring an internal reallocation of assets and earnings streams within the Sumitomo group.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen520.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
More about Sumitomo Chemical Co
Sumitomo Chemical Co. is a diversified Japanese chemical manufacturer with operations spanning petrochemicals, energy and functional materials, IT-related chemicals, health and crop sciences, and pharmaceuticals. Through its consolidated subsidiary Sumitomo Pharma Co., Ltd., the group is active in the prescription drug market, with a particular focus on key products in the United States and growth opportunities in Asian pharmaceutical businesses.
Average Trading Volume: 14,407,771
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen832B
For an in-depth examination of 4005 stock, go to TipRanks’ Overview page.